Hydrochlorothiazide

氢氯噻嗪

Report date: 2026/03/23 20:03:44
NME

Base Information

Drug NameHydrochlorothiazide
Drug Alias NameHidroclorotiazida二氢氯噻氢氯苯塞Hydrochlorothiazidum双氢克尿噻 +[11] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionThiazide-sensitive sodium-chloride cotransporter inhibitors
TargetsThiazide-sensitive sodium-chloride cotransporter
Therapy Area/IndicationsChronic PainEdemaEssential Hypertension +[9] 
Global Approved IndicationsEdemaHypertensionKidney Calculi +[4] 
Approved Indications in ChinaEdemaHypertensionKidney Calculi +[4] 
Original Approved Country/TerritoryUnited States
Original Approved Date1959/02/12
Country/TerritoryBelgiumUnited StatesNetherlands +[9] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesNovartis Pharma Ag
China Registration ClassN/A

Develop Information

Active CompaniesNovitium PharmaUniversity Medical Center GroningenUniversity Of Texas Medical Branch +[7] 
Inactive CompaniesC.H. Boehringer Sohn Ag & Co. KgMylan Pharmaceuticals IncIldong Pharmaceutical Co Ltd +[6] 
Active IndicationsChronic PainEdemaHypertension +[8] 
Inactive IndicationsEssential Hypertension

Other Information

ATC CodeC03AA03
Related LinksWikipediaDrugBankKEGG